A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects
Mayo Clinic · Exocrine Pancreatic Insufficiency · Chronic Pancreatitis
Phase 4
Recruiting
24
2026-07
A source-linked view of every Secretin study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
Largest indexed study
9,000 participants · NCT02000089 →Developer / research origin
Multiple
Evidence summary
Secretin appears in 53 indexed studies: 5 recruiting, 26 completed and 8 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Secretin is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Completed studies
Stopped studies
Mayo Clinic · Exocrine Pancreatic Insufficiency · Chronic Pancreatitis
Phase 4
Recruiting
24
2026-07
Erasmus Medical Center · Liver Transplantation
Phase 1 / Phase 2
Enrolling by invitation
20
2026-06
Children's Hospital Medical Center, Cincinnati · Pancreatitis · Diabetes Mellitus
Phase 4
Enrolling by invitation
195
2026-03
University of California, Los Angeles · Anorexia in Adolescence
Not applicable
Recruiting
10
2026-02
M.D. Anderson Cancer Center · Pancreatitis
Not applicable
Recruiting
2,345
2025-10
Johns Hopkins University · Pancreas Cancer · Peutz-Jeghers Syndrome (PJS)
Phase 3
Recruiting
9,000
2025-10
Mayo Clinic · Chronic Pancreatitis
Phase 1 / Phase 2
Completed
27
2024-09
Indiana University · Obsessive Compulsive Disorder (OCD)
Phase 2
Completed
12
2024-02
Adenocyte, LLC · Pancreas Adenocarcinoma · Dysplasia
Not applicable
Completed
12
2024-02
Indiana University · Cholangiopancreatography, Endoscopic Retrograde
Not applicable
Completed
8
2023-09
Mayo Clinic · Pancreatic Cancer
Not applicable
Completed
346
2023-06
Meridian Bioscience, Inc. · Chronic Pancreatitis · Healthy Volunteers
Phase 2
Completed
33
2022-12
Orlando Health, Inc. · Abdominal Pain · Irritable Bowel Syndrome
Phase 3
Terminated
27
2024-04
University Hospitals Cleveland Medical Center · Pancreas Cancer
Early Phase 1
Withdrawn
0
2022-06
Johns Hopkins University · Cellular Diagnosis, Pancreatic Cancer · Autoimmune Pancreatitis
Not applicable
Withdrawn
0
2019-01
Elizabeth Hecht · Pancreatic Cancer · Intraductal Papillary Mucinous Neoplasm
Not applicable
Withdrawn
0
2016-06
Columbia University · Pancreatic Cancer
Not applicable
Withdrawn
0
2015-04
Mayo Clinic · Pancreatic Cancer
Phase 1 / Phase 2
Terminated
4
2013-06
Full study index
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
53 matching studies
Last registry update first
Latest publications
Related pages
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.